Form 4: Phio Pharmaceuticals Corp. Executive Caitlin Kontulis Reports Share Transaction
SEC Form 4 Filing
Caitlin Kontulis, Secretary & VP Finance & Admin of Phio Pharmaceuticals Corp., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 1, 2024, Caitlin Kontulis, Secretary & VP Finance & Admin of Phio Pharmaceuticals Corp., had shares withheld by the issuer to cover tax obligations related to the vesting of restricted stock units.
- A total of 335 shares of common stock were withheld at a price of $0.958 per share.
- Following the transaction, Kontulis directly owns 10,643 shares, which includes shares of common stock underlying unvested restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of an insider transaction related to tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine Form 4 filing, which is standard practice when company insiders conduct transactions involving the company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related share withholding.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of share withholding transaction. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, insider trading, share transaction, restricted stock units, Caitlin Kontulis, Phio Pharmaceuticals Corp.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.